CD274 and neoplasm: For example, the PD-L1 inhibitor durvalumab, when combined with the CD40 agonist sotigalimab and gemcitabine/nano-albumin-bound paclitaxel, has been shown to enhance NK cell-mediated tumor destruction and improve overall treatment efficacy [160].